Citations

Showing 10 of 108083 citations.

Nonoperative Management of Osteochondritis Dissecans: Progression to Osteoarthritis and Arthroplasty over a 35-Year Period in a Geographic Population
Sanders, Thomas L. , Pareek, Ayoosh , Johnson, Nick R., Carey, James L. , Krych, Aaron J. , Maak, Travis G. , Stuart, Michael J.

Mayo Clinic

Orthopaedic Journal of Sports Medicine | July 31, 2017 | Volume: 5 | Issue: 7_suppl6 | Pages: No page available

10.1177/2325967117s00342 Get It

Objectives: Osteochondritis dissecans (OCD) is a disorder of subchondral bone that commonly affects the knee.The purpose of this study is to (1) evaluate the rate of arthritis and knee arthroplasty in a population-based cohort of patients with OCD lesions treated non-operatively and (2) evaluate factors that may predispose patients to knee osteoarthritis and arthroplasty. Methods: 86 patients (mean age 21.4 years) with OCD lesions treated nonoperatively were identified between 1976 and 2014. Information related to the diagnosis, laterality of lesion, details of treatment, and progression to arthritis was obtained from the medical record. Factors predictive of arthritis and arthroplasty (age, gender, body mass index, and lesion location) were examined. Results: At a mean follow-up of 12.6 (±9.8) years from diagnosis, 13 patients (15%) were diagnosed with arthritis corresponding to a cumulative incidence of 5.0% at 5 years, 10.0% at 10 years, 20.0% at 25 years, and 30.0% at 35 years. The cumulative incidence of arthroplasty was 1.0% at 5 years, 3.0% at 10 years, 8.0% at 25 years, and 8.0% at 35 years. BMI greater than 25 kg/m 2 (HR 15.4, 95% CI: 1.9, 124.5) and patellar OCD lesions (HR 15.0, 95% CI: 1.3, 345.3) were associated with arthritis. Conclusion: Arthritis following nonoperative treatment of OCD lesions is a challenging problem with an estimated 30% cumulative incidence at 35 years after diagnosis. In contrast, the long-term rate of arthroplasty is low. BMI greater than 25 kg/m 2 and patellar OCD lesions are predisposing factors for arthritis. Older age at diagnosis was associated with a greater risk of arthritis and knee arthroplasty.
Can Competitive Athletes Sustain High-Level Play Following Osteochondral Allograft Transplantation of the Knee?
McCarthy, Mark A., Meyer, Maximilian A. , Weber, Alexander E. , Levy, David M. , Tilton, Annemarie K. , Yanke, Adam B. , Cole, Brian J.

Mayo Clinic

Orthopaedic Journal of Sports Medicine | July 31, 2017 | Volume: 5 | Issue: 7_suppl6 | Pages: No page available

10.1177/2325967117s00334 Get It

Objectives: The purpose of this study is to investigate the ability of competitive athletes to remain at a high level of competition following osteochondral allograft transplantation (OCA) of the knee. Methods: A retrospective review was performed to identify all competitive athletes (high school, collegiate, professional) who underwent an isolated femoral condyle OCA between 2004 and 2012. Patient reported outcome (PRO) questionnaires (Lysholm, International Knee Documentation Committee (IKDC), Knee Injury and Osteoarthritis Outcome Score (KOOS), Western Ontario and McMasters Universities Arthritis Index (WOMAC), Short Form-12 (SF-12), Tegner, and Marx) and custom return-to-sport surveys were administered. All subsequent reoperations were documented. Results: A total of 13 (7 male, 6 female) athletes were identified with an average follow-up of 5.9 ± 2.5 years. Four athletes competed at an intercollegiate level, while 9 played high-level high-school sports. Seven athletes returned to competitive sport (54%) at an average of 7.9 ± 3.5 months, five of whom were returned to pre-injury levels of play. Of the eight athletes who either did not return to sport or failed to sustain their high level of play, the most common reasons cited were a change in life circumstances, such as graduation, or a fear of re-injury (Figure 1). At final follow-up, regardless of return-to-play, all athletes had significant improvements in all PRO scores except for KOOS-Sport, WOMAC-Stiffness, and SF-12 Mental subscales. Tegner Activity scores dropped significantly from pre-injury to final follow-up (8.2 ± 2.4, 4.5 ± 2.1, p < 0.01). There were three reoperations and zero instances of graft failure. Conclusion: OCAs provide acceptable rates of return-to-play and excellent long-term outcomes for high-level athletes with large osteochondral defects. Social factors are three times more likely than persistent pain to prevent return to sport.
Increased Risk of Graft Failure after ACL Reconstruction in Young Female Athletes with Hamstring Grafts
Paterno, Mark V. , Thomas, Staci , Magnussen, Robert A. , Schmitt, Laura C. , Hewett, Timothy E.

Mayo Clinic

Orthopaedic Journal of Sports Medicine | July 31, 2017 | Volume: 5 | Issue: 7_suppl6 | Pages: No page available

10.1177/2325967117s00301 Get It

Objectives: The incidence of second anterior cruciate ligament (ACL) injury after ACL reconstruction (ACLR) and return to sport (RTS) in a young, active population is likely between 25-33% with the greatest risk in the first 12 months after RTS. Although the use of allograft tissue in young athletes has been reported to result in increased risk of graft failure, differences in graft and contralateral ACL injury risk between patients who receive a hamstrings (HS) autograft and bone-patellar tendon- bone (BTB) autograft has yet to be reported in a young, athletic population. The tested hypothesis was that the relative risk (RR) of ipsilateral graft failure would be higher in young, active patients who receive an ACLR with a hamstrings graft, while the RR of contralateral ACL injury would be higher in patients who receive and ACLR with a BTB autograft. Methods: One hundred thirty-nine subjects (99 female/40 male) with a mean age of 16.9±2.0 years old (range: 13-25 y/o) underwent ACLR with either a HS autograft (n=79) or a BTB autograft (n=60) and were released to return to pivoting/cutting sport. These patients were enrolled in a prospective, observational cohort study and were tracked for incidence of 2 nd ACL after ACLR for a median of 73 months. Thirty-four (24.5%) suffered a 2 nd ACL injury. Fisher’s exact tests were used to determine whether graft choice (HS vs. BTB) was associated with risk of either ipsilateral graft failure or contralateral ACL injury. Sub-group analyses by sex were also conducted. Results: Patients who underwent ACLR with HS graft (n=79) sustained 14 ipsilateral tears and 6 contralateral ACL injuries. Patients who received an ACLR with BTB (n=62) sustained 2 ipsilateral tears and 12 contralateral ACL injuries (Table 1). Patients who received an ACLR with HS graft were 6 times more likely (RR=6.2; 95% CI: 1.4-28.7) to suffer a graft failure after RTS than the BTB group. In the first 12 months after RTS, the HS graft patients were nearly 10 times (RR=9.5; 95% CI: 1.2-76.1) more likely to suffer an ipsilateral graft failure. Patients with a HS graft were 3 times less likely (RR=0.33; 95%CI: 0.12-0.935) to suffer a contralateral ACL injury and nearly 7 times less likely (RR=0.15, 95%CI: 0.031-0.709) to suffer a contralateral ACL injury in the first 12 months after RTS compared to the BTB group. When the cohort was divided by sex, females with HS grafts were significantly more likely to sustain a graft failure in the first 12 months after RTS (p=0.008) and by final follow-up (p=0.002) compared to females with BTB graft. Females with HS grafts were 3 times less likely (RR=0.30; 95%CI: 0.095-0.943) to suffer a contralateral ACL injury than females with BTB graft and 6 times less likely (RR=0.17; 95%CI: 0.034-0.846) to suffer contralateral ACL injury in the first year after RTS. Males demonstrated no significant difference in ipsilateral or contralateral injury risk based on graft type. Conclusion: Young, active females who return to pivoting and cutting sports after ACLR with HS autograft are at greater risk to suffer a graft failure and reduced risk to suffer a contralateral ACL injury compared to females who undergo ACLR with BTB graft tissue. No significant differences in 2 nd ACL injury risk based on graft type were observed in the male patients. [Table: see text]
Partial Meniscectomy Provides No Benefit for Symptomatic Degenerative Medial Meniscus Posterior Root Tears
Johnson, Nick R., Mohan, Rohith , Dahm, Diane L., Levy, Bruce A. , Krych, Aaron J. , Stuart, Michael J.

Mayo Clinic

Orthopaedic Journal of Sports Medicine | July 31, 2017 | Volume: 5 | Issue: 7_suppl6 | Pages: No page available

10.1177/2325967117s00241 Get It

Objectives: Medial meniscus posterior root tears (MMPRTs) are recognized as a source of pain and dysfunction, but treatment options remain a clinical challenge. Currently, outcomes are unknown following partial meniscectomy for these lesions. To determine (1) the efficacy of partial meniscectomy to treat MMPRTs compared to a matched group of non-operatively treated MMPRTs, and (2) risk factors for worse clinical and radiographic outcome. Methods: This retrospective comparative study was performed to include 27 patients with MMPRTs that were treated with arthroscopic partial meniscectomy (PMM) and a minimum 2-year follow-up. These patients were then matched by age, gender, and BMI to a group of 27 patients with MMPRTs treated non-operatively (control group). Demographic data, radiographic findings, final Tegner and IKDC scores were obtained and compared between the two groups. Risk factors for worse clinical and radiographic outcome in the PMM group alone, including age, sex, BMI, initial K-L grade, subchondral edema, and insufficiency fracture on MRI were determined. Results: Overall, 54 patients were included in the study. 27 patients (10M: 17F) with a mean age of 55±9 and a mean BMI of 32.8±5.3 were treated with PMM and followed for a mean of 5.5±2 years (range 2.3-9.3 years). In the PMM group, final median Tegner score was 3, mean IKDC scores were 67.8±20, median KL grades on weight-bearing AP films demonstrated progressive arthritis (median grade 1 to 2, p=0.001) and more patients had grade II or higher arthritis at final follow-up than baseline (91.3% vs. 36% p<0.01. Overall, 14 of the 27 patients (52%) treated operatively progressed to total knee arthroplasty at a mean of 54.3 months. When comparing the PMM and control groups, there was no significant difference in final median Tegner scores, mean IKDC, median K-L grades, progression to arthroplasty, or overall failure rate. Following PMM, female patients had lower final IKDC scores (74.6±16.7 vs. 44.00±2.8, p=0.02) compared to males, as well as a higher rate of arthroplasty (70.6% vs, 20.0%, p=0.009). Higher BMI correlated with lower IKDC scores (r=-0.91, p=0.01) and meniscal extrusion was associated with higher rate of arthritis at final follow-up (100% vs. 57%, p=0.02). Conclusion: Partial meniscectomy for a MMRT provides no benefit in halting arthritic progression. Patients who undergo arthroscopic debridement for MMPRTs still progress to significant arthritis, poor clinical outcomes and a high arthroplasty rate (52%) at over 5-year follow-up. Compared to a non-operative control group, there was no benefit in any subjective or objective outcome measures from the arthroscopic partial meniscectomy. Female patients, higher BMI, and presence of meniscus extrusion were associated with worse outcomes and a higher rate of subsequent knee arthroplasty.
Operative Management of Osteochondritis Dissecans: Progression to Osteoarthritis and Arthroplasty in a Population Based Cohort
Sanders, Thomas L. , Pareek, Ayoosh , Johnson, Nick R., Mohan, Rohith , Carey, James L. , Stuart, Michael J. , Krych, Aaron J.

Mayo Clinic

Orthopaedic Journal of Sports Medicine | July 31, 2017 | Volume: 5 | Issue: 7_suppl6 | Pages: No page available

10.1177/2325967117s00234 Get It

Objectives: Osteochondritis dissecans (OCD) is a disorder of subchondral bone that causes adverse effects on the overlying cartilage and commonly affects the knee. The purpose of this study is to (1) evaluate the rate of arthritis and knee arthroplasty in a population-based cohort of patients with OCD lesions treated operatively and (2) evaluate factors that may predispose patients to knee osteoarthritis and arthroplasty. Methods: 221 patients (mean age 26.1 ± 13.6 years) with OCD lesions treated operatively were identified between 1976 and 2014 and followed for a mean of 16.3 (±11.4) years from diagnosis. Information related to the diagnosis, laterality of lesion, details of treatment, and progression to arthritis was obtained from the medical record. Surgical treatment was classified as palliative (fragment excision) or restorative (lesion drilling, fragment fixation, osteochondral allograft or autograft). Factors predictive of arthritis and arthroplasty were examined. Results: In the palliative group, the cumulative incidence of arthritis was 12.0% at 5 years, 17.0% at 10 years, 26.0% at 15 years, 39.0% at 20 years, and 70% at 30 years. The cumulative incidence of arthroplasty was 2.0% at 5 years, 4.0% at 10 years, 4.0% at 15 years, 10.0% at 20 years, and 32.0% at 30 years. In the restorative group, the cumulative incidence of arthritis was 3.0% at 5 years, 7.0% at 10 years, 16.0% at 15 years, 25.0% at 20 years, and 51% at 30 years. The cumulative incidence of arthroplasty was 0.0% at 5 years, 0.0% at 10 years, 3.0% at 15 years, 6.0% at 20 years, and 11.0% at 30 years. BMI greater than 25 kg/m 2 (HR 3.3, 95% CI: 1.6, 7.0), older age at diagnosis (HR 4.9, 95% CI: 1.8, 17.3) and fragment excision (HR 2.3, 95% CI: 1.2, 4.6) were predictive of arthritis. Conclusion: OCD patients treated with fragment excision have a high rate of arthritis and knee arthroplasty at long-term follow-up. In contrast, patients treated with fragment repair or osteochondral restoration have lower rates of arthritis and arthroplasty. BMI greater than 25 kg/m 2 , older age at diagnosis, and fragment excision were predictive of arthritis.
What is the Natural History of Patellar Dislocation in Skeletally Immature Patients?
Sanders, Thomas L. , Pareek, Ayoosh , Dahm, Diane L., Hewett, Timothy E. , Stuart, Michael J. , Krych, Aaron J.

Mayo Clinic

Orthopaedic Journal of Sports Medicine | July 31, 2017 | Volume: 5 | Issue: 7_suppl6 | Pages: No page available

10.1177/2325967117s00213 Get It

Objectives: Patellar dislocation can occur in isolation or be associated with chronicinstability. The goals of this study are to describe the rate and factors associated with additional patellar instability events (ipsilateral recurrence and contralateral dislocation), as well as the incidence of patellofemoral arthritis among skeletally immature patients following patellar dislocation. Methods: The study included a population-based cohort of 232 skeletally immature patients who experienced a first-time lateral patellar dislocation between 1990 and 2010. A chart review was performed to collect information related to the initial injury, treatment, and outcomes. Subjects were followed for a mean of 12.1 years to determine the rate of subsequent patellar dislocation (ipsilateral recurrence or contralateral dislocation) as well as clinically significant patellofemoral arthritis. Results: 104 patients had ipsilateral recurrent patellar dislocation. The cumulative incidence of recurrent dislocation was 11% at 1 year, 21.1% at 2 years, 37.0% at 5 years, 45.1% at 10 years, 54.0 % at 15 years, and 54.0% at 20 years. Patella alta (HR: 10.6, 95% CI: 3.6, 36.1), increased TT-TG distance (HR 18.7, 95% CI: 1.7, 228.2), and trochlear dysplasia (HR 23.7, 95% CI: 1.0, 105.2) were associated with recurrence. Similarly, 18 patients (7.8%) had contralateral patellar dislocation. The cumulative incidence of patellofemoral arthritis was 0% at 2 years, 1.0% at 5 years,2.0% at 10 years, 10.1% at 15 years, 17%% at 20 years, and 39.0% at 25 years. Osteochondral injury was associated with arthritis (HR 25.7, 95% CI: 6.2, 143.8). Conclusion: Skeletally immature patients have a high rate of recurrent patellarinstability that is associated with structural abnormalities such as patella alta and trochlear dysplasia. In contrast, the rate of subsequent contralateral dislocation is low. Osteochondral injury is associated with arthritis after patellar dislocation, but the overall incidence of symptomatic arthritis with advanced radiographic changes in pediatric patients is low at 12-year follow-up.
Differential characteristics, stroke recurrence, and predictors of covert atrial fibrillation of embolic strokes of undetermined source
Pertierra, Lucía , Schneider, Maia Gómez , Pastor-Rueda, José M, Hawkes, Maximiliano A. , Farez, Mauricio , Rueda, José Manuel Pastor , Ameriso, Sebastian Francisco

Mayo Clinic

International Journal of Stroke | July 31, 2017 | Volume: 13 | Issue: 2 | Pages: 190-194

10.1177/1747493017724624 | PMID 28756759 Get It

Background and purpose Identifying embolic strokes of undetermined source (ESUS) patients likely to harbor atrial fibrillation may have diagnostic and therapeutic implications. Our aim was to examine differences between ESUS and cardioembolic strokes, to evaluate stroke recurrence rate among ESUS and to identify baseline characteristics of ESUS patients who were later diagnosed with atrial fibrillation. Materials and methods We assessed all ischemic stroke patients admitted between June 2012 and November 2013. ESUS were compared to cardioembolic strokes at discharge. After at least 12-month follow-up, ESUS patients diagnosed with atrial fibrillation were compared to those who remained as ESUS. Results There were 236 ischemic strokes, 32.6% were ESUS. Compared to cardioembolic strokes, ESUS were younger (p < 0.0001), had milder strokes (p < 0.05), less prevalence of hypertension (p < 0.05), peripheral vascular disease (p < 0.05), and previous ischemic stroke (p < 0.05). After follow-up, 15% of ESUS patients had stroke recurrences and 12% evidenced paroxysmal atrial fibrillation. ESUS patients diagnosed with atrial fibrillation in the follow-up were older (p < 0.0001), had higher erythrocyte sedimentation rate (p < 0.05), and were more likely to have ≥2 infarcts in the same arterial territory in the initial magnetic resonance imaging (p < 0.05). Conclusions Older age, small-scattered infarcts on initial magnetic resonance imaging and high erythrocyte sedimentation rate levels appear to identify ESUS patients more likely to be diagnosed of atrial fibrillation during follow-up.
Reprocessing of single-use endoscopic variceal band ligation devices: a pilot study
Visrodia, Kavel , Hanada, Yuri , Pennington, Kelly M. , Clemens, Magdalen A., Pearce, Paul, Tosh, Pritish K. , Petersen, Bret, Topazian, Mark , Haseeb, Abdul, Clemens, Magdalen, Haseeb, Abdul

Mayo Clinic

Endoscopy | July 28, 2017 | Volume: 49 | Issue: 12 | Pages: 1202-1208

10.1055/s-0043-115004 | PMID 28753701 Get It

Abstract Background and study aims The preferred management of bleeding esophageal varices includes endoscopic band ligation. Endoscopic ligation devices (ELDs) are expensive and designed for single use, limiting their uptake in developing countries. We aimed to assess the efficacy of reprocessing ELDs using terminal microbial cultures and adenosine triphosphate (ATP) testing. Materials and methods ELDs were recovered after clinical use and their components (cap, handle, and cord) were subjected to reprocessing. This included manual cleaning, automated high-level disinfection (HLD), and drying with forced air. Using sterile technique, ELD components were sampled for ATP at three stages: before manual cleaning, after manual cleaning, and after HLD. Components were sent to an external laboratory for culturing. Cultures were interpreted as positive upon identification of Gram-negative bacilli. Results A total of 14 clinically used ELDs were studied, and 189 ATP tests and 41 cultures were evaluated. Overall, 95 % (39/41) of components and 86 % (12/14) of ELDs were culture-negative or did not yield Gram-negative bacilli. Two components (5 %; one handle and one cord) harbored Gram-negative bacilli in quantities of 1 CFU per component. There was no apparent correlation between ATP at any juncture of reprocessing and terminal cultures. Conclusions Reprocessing of ELDs is effective, resulting in infrequent and minimal microbial contamination. Microbial culturing can be used to ensure adequacy of ELD reprocessing if pursued. Until reusable ELDs are commercially available, continued efforts to better define the adequacy and long-term effects of reprocessing ELDs are needed.
Molecular and Clinical Approach to Intra-abdominal Adverse Effects of Targeted Cancer Therapies
Chang, Stephanie T. , Menias, Christine O. , Lubner, Meghan G. , Mellnick, Vincent M. , Hara, Amy K., Desser, Terry S. , Mellnick, Vincent

Mayo Clinic

RadioGraphics | July 28, 2017 | Volume: 37 | Issue: 5 | Pages: 1461-1482

10.1148/rg.2017160162 | PMID 28753381 Get It